Patents by Inventor Byong-Sun Choi

Byong-Sun Choi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical composition for the prevention or treatment of osteoarthritis containing rebamipide as an active ingredient
    Patent number: 9301954
    Abstract: The present invention provides a method for preventing or treating osteoarthritis comprising administrating rebamipide or a pharmaceutical composition comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier to a subject in need thereof. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
    Type: Grant
    Filed: March 4, 2011
    Date of Patent: April 5, 2016
    Assignees: HANLIM PHARMACEUTICAL CO., LTD, CATHOLIC UNIVERSITY ACADEMIC COOPERATION FOUNDATION
    Inventors: Jun-Ki Min, Mi-La Cho, Yun-Ju Woo, Hye-Jwa Oh, Young-Ok Jung, Geun-Hyeog Lee, Byong-Sun Choi, Jin-Ha Park, Eun-Young Kwak
  • Door rail system
    Patent number: 9303444
    Abstract: A door rail system for mounting a pane includes a clamp housing having a tapered projection and a pair of clamps having a recess. A screw fastens the clamps together from a side of the clamp housing so that the recesses and tapered projection are configured to form a secure dovetail joint for holding a pane. The recesses (and clamps) are symmetrical and the tapered projection is at the center so that a pane can be securely held at the center without being tilted. The door rail system includes an accessory channel and first and second mounting members. The first and second mounting members are slidably attached to each other by a sliding dovetail joint so that each mounting member can slide against the other mounting member.
    Type: Grant
    Filed: February 25, 2015
    Date of Patent: April 5, 2016
    Inventor: Kevin Byong Sun Choi
  • Pharmaceutical composition including mometasone furoate and azelastine hydrochloride for nasal administration
    Patent number: 8859531
    Abstract: The present invention provides a pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride, wherein the pharmaceutical composition comprises thaumatin as an agent for reducing bitterness and irritation.
    Type: Grant
    Filed: November 18, 2011
    Date of Patent: October 14, 2014
    Assignee: Hanlim Pharmaceutical Co., Ltd
    Inventors: Sang-Yong Lee, Geun-Hyeog Lee, Byong-Sun Choi, Jong-Hyeon Ryu, Jin-Ha Park, Mi-Jin O
  • PHARMACEUTICAL COMPOSITION INCLUDING MOMETASONE FUROATE AND AZELASTINE HYDROCHLORIDE FOR NASAL ADMINISTRATION
    Publication number: 20130252929
    Abstract: The present invention provides a pharmaceutical composition for nasal administration comprising mometasone furoate and azelastine hydrochloride, wherein the pharmaceutical composition comprises thaumatin as an agent for reducing bitterness and irritation.
    Type: Application
    Filed: November 18, 2011
    Publication date: September 26, 2013
    Applicant: HANLIM PHARMACEUTICAL CO., LTD.
    Inventors: Sang-Yong Lee, Geun-Hyeog Lee, Byong-Sun Choi, Jong-Hyeon Ryu, Jin-Ha Park, Mi-Jin O.
  • PHARMACEUTICAL COMPOSITION FOR THE PREVENTION OR TREATMENT OF OSTEOARTHRITIS CONTAINING REBAMIPIDE AS AN ACTIVE INGREDIENT
    Publication number: 20130065920
    Abstract: The present invention provides a pharmaceutical composition for preventing or treating osteoarthritis comprising rebamipide as an active ingredient and a pharmaceutically acceptable carrier. The pharmaceutical composition may be for oral administration, for example an oral solid dosage form of a tablet or capsule form. The pharmaceutical composition may be formulated into a unit dosage form suitable for orally administering rebamipide in a dose ranging from 0.5 to 50 mg/kg, preferably from 0.6 to 6 mg/kg.
    Type: Application
    Filed: March 4, 2011
    Publication date: March 14, 2013
    Applicant: HANLIM PHARMACETICAL CO., LTD.
    Inventors: Jun-Ki Min, Mi-La Cho, Yun-Ju Woo, Hye-Jwa Oh, Young-Ok Jung, Geun-Hyeog Lee, Byong-Sun Choi, Jin-Ha Park, Eun-Young Kwak